Pharmacy

With $15M discovery deal, Boehringer becomes latest Big Pharma to buy into Immunai’s AI platform
- TechBio outfit Immunai is continuing its parade of Big Pharma partnerships with its third such pact this year, this time with German drugmaker Boehringer Ingelheim.


